BioCryst Pharmaceuticals, Inc. (FRA:BO1)
Germany · Delayed Price · Currency is EUR 6.06
+0.02 (0.36%)
At close: Dec 1, 2025
BioCryst Pharmaceuticals Market Cap
BioCryst Pharmaceuticals has a market cap or net worth of €1.3 billion as of December 1, 2025. Its market cap has decreased by -12.88% in one year.
Market Cap
1.30B
Enterprise Value
1.71B
Revenue
511.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
€6.06
Market Cap Chart
Since March 4, 1994, BioCryst Pharmaceuticals's market cap has increased from 19.07M to 1.30B, an increase of 6,735.02%. That is a compound annual growth rate of 14.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 1.29B | -14.17% |
| Dec 31, 2024 | 1.50B | 35.56% |
| Dec 29, 2023 | 1.11B | -44.58% |
| Dec 30, 2022 | 2.00B | -8.62% |
| Dec 31, 2021 | 2.19B | 103.78% |
| Dec 31, 2020 | 1.08B | 127.05% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |